Bristol-Myers Squibb Stock Analysis Intraday levels of Bristol-Myers Squibb Companys stock (BMY) saw a rise, managing to surpass the important resistance level of $53.55. The dominance of an upward correctional trend in the short term, along with positive pressure from the 50-day SMA, and signals from the RSI after reaching oversold levels, contributed to the bullish sentiment. Forecast and Analysis Considering the current trends and indicators, we anticipate further gains in the stock price, targeting the resistance level of $57.65.

If the stock settles above $53.55, it would support this bullish outlook.

Trend Forecast Likely Bullish